FDA CLEARED
Digital Lung Acoustics for Better Insight
As Featured In
See the Full Respiratory Picture
Assessing patient lung health remotely is a challenge, with traditional auscultation limited to in-person visits and patient self-reporting of symptoms subjective. Our technology continuously measures cough and lung sounds in connection with treatment plans, allowing for greater insights to improve care, research studies and drug development.
For Healthcare
Manage lung health from hospital to home with real-time monitoring of symptoms
For Life Sciences
Gain greater, objective insight into subject treatment response in clinical trials
How It Works
An end-to-end solution for remote monitoring of lung health
RESP® Biosensor
Patient adheres device to their chest and device continuously captures lung sounds throughout the day and night
Strados™ Mobile App
Lung sound data collected by the device is transferred to a companion patient mobile app via Bluetooth
Strados™ Cloud
Cloud securely stores data where lung sound events such as cough and wheeze are tracked and trended
600k+
19m+
4
35
2
1
The Award-Winning Technology Revolutionizing Lung Health
Privacy & Security
Designed for Daily Life
Low-burden, discreet design aids patient comfort while accurately collecting data in the real world.
Global Experience
Used in patients and subjects in four continents and 35 languages.
Beyond Cough
Extended capabilities beyond cough frequency include intensity, bouts, lung sounds and vitals* for a fuller understanding of patient health.
Clinically Validated Accuracy
*Measurement not FDA-cleared
FAQ
Strados Labs Frequently Asked Questions
News & Resources
Strados to Participate in DiMe Project: Building the Business Case for Digital Endpoints
Strados Labs is excited to announce its participation in a groundbreaking project led by the Digital Medicine Society (DiMe), a global non-profit dedicated to driving scientific progress and broad acceptance in digital medicine. The project, Building the Business Case...
Strados Labs featured at the Respiratory Innovation Summit at ATS 2024
Strados Labs returned to the Respiratory Innovation Summit (RIS), taking place at ATS 2024 in San Diego, CA where Strados was also an exhibitor (Booth 1131). RIS took place from May 17-18. Hosted by the American Thoracic Society, the Respiratory Innovation Summit...
Unpacking the FDA Advisory Committee Meeting for Merck’s Gefapixant
In November 2023, Merck's chronic cough drug, gefapixant, faced a decisive setback from the FDA Advisory Committee. The concerns highlighted insufficient evidence for the drug providing a clinically meaningful benefit to adults with refractory chronic cough (RCC) or...
Let's Talk
Speak to one of our respiratory experts to learn more